Notch2, Notch4 gene polymorphisms in psoriasis vulgaris

European Journal of Dermatology

Volumn 23, Issue 2, 2013, Pages 146-153

  Michailidis, Charalambos ^a   Karpouzis, Anthony ^a   Kourmouli, Niki ^a   Tripsianis, Gregory ^a   Diplas, Andreas ^b   Veletza, Stavroula ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Genetic polymorphisms in psoriasis; Notch2 gene polymorphisms; Notch4 gene polymorphisms; Psoriasis genetics; Psoriasis in females; Psoriasis in males

Indexed keywords

NOTCH2 RECEPTOR; NOTCH4 RECEPTOR;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DNA FLANKING REGION; EXON; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOTCH2 GENE; NOTCH4 GENE; ONSET AGE; PRESCHOOL CHILD; PSORIASIS VULGARIS; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC POLYMORPHISMS IN PSORIASIS; NOTCH2 GENE POLYMORPHISMS; NOTCH4 GENE POLYMORPHISMS; PSORIASIS GENETICS; PSORIASIS IN FEMALES; PSORIASIS IN MALES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; PSORIASIS; RECEPTOR, NOTCH2; RECEPTORS, NOTCH; SEX FACTORS; YOUNG ADULT;

EID: 84877761351     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2013.1985     Document Type: Article

References (39)

1. Giardina E, Sinibaldi C, Novelli G. The psoriasis genetics as a model of complex disease. Curr Drug Targets Inflamm Allergy 2004; 3: 129-36.
2. Valdimarsson H. The genetic basis of psoriasis. Clin Dermatol 2007; 25: 563-7.
3. Oka A, Mabuchi T, Ozawa A, Inoko H. Current understanding of human genetics and genetic analysis of psoriasis. J Dermatol 2012; 39:231-41. doi: 10.1111/j.1346-8138.2012.01504.x.
4. Roberson ED, Bowcock AM. Psoriasis genetics: breaking the barrier. Trends Genet 2010; 26: 415-23.
5. Okuyama R, Nguyen BC, Talora C, et al. High commitment of embryonic keratinocytes to terminal differentiation through a Notch1- caspase 3 regulatory mechanism. Dev Cell 2004; 6: 551-62.
6. Thelu J, Rossio P, Favier B. Notch signaling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing. BMC Dermatol 2002; 2: 1-12.
7. Okuyama R, Tagami H, Aiba S. Notch signaling: Its role in epidermal homeostasis and in the pathogenesis of skin diseases. J Dermatol Sci 2008; 49: 187-94.
8. Watt FM, Estrach S, Ambler CA. Epidermal Notch signaling: differentiation, cancer and adhesion. Curr Opin Cell Biol 2008; 20: 171-179.
9. Nickoloff BJ, Qin JZ, Chaturvedi V, Denning MF, Bonish B, Miele L. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma. Cell Death Differ 2002; 9: 842-55.
10. Panelos J, Massi D. Emerging role of Notch signaling in epidermal differentiation and skin cancer. Cancer Biol Ther 2009; 8: 1986-93.
11. Moriyama M, Durham AD, Moriyama H, et al. Multiple roles of Notch signaling in the regulation of epidermal development. Dev Cell 2008; 14: 594-604.
12. Massi D, Tarantini F, Franchi A, et al. Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma. Modern Pathol 2006; 19: 246-54.
13. Proweller A, Tu L, Lepore JJ, et al. Impaired notch signaling promotes de novo squamous cell carcinoma formation. Cancer Res 2006; 66: 7438-44.
14. Liu Z-L, Li Y, Kong Q-Y, et al. Immunohistochemical profiling of Wnt, NF-kB, Stat 3 and Notch signaling in human epidermal tumors. J Dermatol Sci 2008; 52: 133-5.
15. Pinnix CC, Lee JT, Liu ZJ, et al. Active Notch1 confers a transformed phenotype to primary human melanocytes. Cancer Res 2009; 69: 5312-20.
16. Demehri S, Turkoz A, Kopan R. Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. Cancer Cell 2009; 16: 55-66.
17. Wang NJ, Sanborn Z, Arnett KL, et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci USA 2011; 108: 17761-6.
18. Abdou AG, Maraee AH, Sharaf A, Elnaidany NF. Up-regulation of Notch-1 in psoriasis: an immunohistochemical study. Ann Diagn Pathol 2012; 16: 177-84.
19. Larsson, C., Lardelli, M., White, I., Lendahl, U. The human NOTCH1, 2, and 3 genes are located at chromosome positions 9q34, 1p13-p11, and 19p13.2-p13.1 in regions of neoplasia-associated translocation. Genomics 1994; 24: 253-258.
20. Sugaya, K, Fukagawa T, Matsumoto K et al. Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a Notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics 1994; 23: 408-419.
21. Veal CD, Clough RL, Barber RC, et al. Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J Med Genet 2001; 38: 7-13.
22. Balendran N, Clough RL, Arguello JR, et al. Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Invest Dermatol 1999; 113: 322-8.
23. Leong KG, Hu X, Li L, et al. Activated Notch4 inhibits angiogenesis: role of beta 1-integrin activation. Mol Cell Biol 2002; 22: 2830-41.
24. Blanpain C, Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 2009; 10: 207-17.
25. Braverman IM, Yen A. Ultrastructure of the capillary loops in the dermal papillae of psoriasis. J Invest Dermatol 1977 Jan;68: 53-60.
26. Creamer D, Sullivan D, Bicknell R, Barker J. Angiogenesis in psoriasis. Angiogenesis 2002; 5: 231-6.
27. Heidenreich R, Röcken M, Ghoreschi K. Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol 2009; 90: 232-48.
28. Armstrong AW, Voyles SV, Armstrong EJ, Fuller EN, Rutledge JC. Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci 2011; 63: 1-9.
29. Raychaudhuri SP. A Cutting Edge Overview: Psoriatic Disease. Clin Rev Allergy Immunol 2012, Feb 23 (Epub ahead of print) DOI 10.1007/s12016-012-8309-z
30. Funahashi Y, Shawber CJ, Sharma A, Kanamaru E, Choi YK, Kitajewski J. Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity. Vasc Cell 2011; 18;3:2.
31. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988; 16: 1215.
32. Ujike H, Takehisa Y, Takaki M, et al. NOTCH 4 gene polymorphism and susceptibility to schizophrenia and schizoaffective disorder. Neurosci Let 2001; 301: 41-4.
33. Prasad S, Chowduri KV, Wood J, et al. Association analysis of Notch 4 polymorphisms with schizophrenia among two independent family based samples. Am J Med Genet Part B (Neuropsychiatric Genetics) 2004; 131B: 6-9.
34. Tien AC, Rajan A, Bellen HJ. A Notch updated. J Cell Biol 2009; 9;184:621-9.
35. Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol 2009; 60: 394-401.
36. Soares R, Balogh G, Guo S, Gärtner F, Russo J, Schmitt F. Evidence for the Notch signaling pathway on the role of estrogen in angiogenesis. Mol Endocrinol 2004; 18: 2333-43.
37. Rizzo P, Miao H, D'Souza G, et al. Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res 2008; 68: 5226.
38. Chen H, Poon A, Yeung C, et al. A genetic risk score combining ten psoriasis risk loci improves disease prediction. PLoS One 2011; 29;6:e19454.
39. Altshuler D, Daly MJ, Lander ES. Genetic mapping in human disease. Science 2008; 7;322:881-8.